Establishment Labs Holdings Inc. (ESTA): Price and Financial Metrics
ESTA Price/Volume Stats
Current price | $48.54 | 52-week high | $73.00 |
Prev. close | $48.95 | 52-week low | $16.96 |
Day low | $45.92 | Volume | 212,600 |
Day high | $48.95 | Avg. volume | 424,552 |
50-day MA | $47.68 | Dividend yield | N/A |
200-day MA | $43.20 | Market Cap | 1.33B |
ESTA Stock Price Chart Interactive Chart >
Establishment Labs Holdings Inc. (ESTA) Company Bio
Establishment Labs Holdings Inc., a medical technology company, designs, develops, manufactures, and markets medical devices for aesthetic plastic surgery, reconstructive plastic surgery, and aesthetic dermatology. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Divina 3D simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and distributes Puregraft line of products that is used to remove blood, lipids, and other components from adipose tissue. The company sells its products through exclusive distributors and direct sales force in 60 countries worldwide. The company was founded in 2004 and is based in Alajuela, Costa Rica.
Latest ESTA News From Around the Web
Below are the latest news stories about ESTABLISHMENT LABS HOLDINGS INC that investors may wish to consider to help them evaluate ESTA as an investment opportunity.
Establishment Labs Announces Participation in Two Upcoming Investment ConferencesNEW YORK, November 10, 2023--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in two upcoming investment conferences. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping tabs on for Thursday morning! |
A Look At The Intrinsic Value Of Establishment Labs Holdings Inc. (NASDAQ:ESTA)Key Insights Using the 2 Stage Free Cash Flow to Equity, Establishment Labs Holdings fair value estimate is US$27.03... |
Establishment Labs Announces National Medical Products Administration Approval for Motiva Implants in ChinaNEW YORK, November 09, 2023--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it has received National Medical Products Administration (NMPA) approval in China for Motiva® Implants. |
Establishment Labs Holdings Inc. (NASDAQ:ESTA) Q3 2023 Earnings Call TranscriptEstablishment Labs Holdings Inc. (NASDAQ:ESTA) Q3 2023 Earnings Call Transcript November 7, 2023 Establishment Labs Holdings Inc. misses on earnings expectations. Reported EPS is $-1.12 EPS, expectations were $-0.72. Operator: Good afternoon. Welcome to Establishment Labs’ Third Quarter 2023 Earnings Call. At this time, all participants will be in a listen-only mode. At the end […] |
ESTA Price Returns
1-mo | -4.37% |
3-mo | 35.21% |
6-mo | 54.00% |
1-year | -29.08% |
3-year | -36.01% |
5-year | 83.59% |
YTD | 87.49% |
2023 | -60.56% |
2022 | -2.87% |
2021 | 79.57% |
2020 | 36.08% |
2019 | 0.88% |
Continue Researching ESTA
Here are a few links from around the web to help you further your research on Establishment Labs Holdings Inc's stock as an investment opportunity:Establishment Labs Holdings Inc (ESTA) Stock Price | Nasdaq
Establishment Labs Holdings Inc (ESTA) Stock Quote, History and News - Yahoo Finance
Establishment Labs Holdings Inc (ESTA) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...